The Patent Finder

Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses

Rigel Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 62/666,462, filed May 3, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 7,449,458Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 10,822,337TGF-ß InhibitorC
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 12,227,508Tgf-ß Inhibitors
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 9,982,000Pyrazole Compounds and Method for Making and Using the Compounds
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 10,208,074Pyrazole Compounds and Method for Making and Using the Compounds
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 10,208,075Pyrazole Compounds and Method for Making and Using the Compounds
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 11,370,808Pyrazole Compounds and Methods for Making and Using the Compounds
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 10,030,005Inhibitors of Ret
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 10,584,114Inhibitors of Ret
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
US 11,279,688Inhibitors of Ret
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In force
High confidence
82 more patents in this group · Pro
10 of 92 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 92, including 22 expired.
Upgrade to Pro
33 of these are in force and held by Rigel Pharmaceuticals, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited